Personalis (PSNL) EBITDA Margin (2018 - 2026)
Personalis (PSNL) posted quarterly EBITDA Margin of 207.87% for Q1 2026, down 12198.0% year-over-year from N/an in Q1 2025, and down 42.7% quarter-over-quarter from 145.67% in Q4 2025.
Personalis (PSNL) EBITDA Margin (2018 - 2026) Analysis & Trends
Personalis' EBITDA Margin history runs 9 years deep, the most recent figure standing at 207.87% for Q1 2026.
- In Q1 2026, EBITDA Margin fell 12198.0% year-over-year to 207.87%; the TTM figure through Mar 2026 stood at 158.91% (down 8063.0% YoY), while the FY2025 annual figure was 126.43%, down 4575.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 207.87%, down from 145.67% in the prior quarter.
- The five-year high for EBITDA Margin was 55.94% in Q3 2024, with the low at 207.87% in Q1 2026.
- The 5-year median for EBITDA Margin is 151.78% (2023), against an average of 139.81%.
- The sharpest annual moves came in 2022 and 2024: EBITDA Margin plunged 12608 bps in 2022, then jumped 11282 bps in 2024.
- Personalis' EBITDA Margin stood at 191.87% in 2022, then soared by 36 bps to 121.84% in 2023, then increased by 12 bps to 107.81% in 2024, then slumped by 35 bps to 145.67% in 2025, then tumbled by 43 bps to 207.87% in 2026.
- Business Quant data shows PSNL's EBITDA Margin at 207.87% in Q1 2026, 145.67% in Q4 2025, and 160.68% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Personalis | 1.40 Bn | 1.17 Bn | 281,000.00 | -207.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -207.87% |
| Dec 31, 2025 | -145.67% |
| Sep 30, 2025 | -160.68% |
| Jun 30, 2025 | -126.75% |
| Mar 31, 2025 | -85.88% |
| Dec 31, 2024 | -107.81% |
| Sep 30, 2024 | -55.94% |
| Jun 30, 2024 | -74.81% |
| Mar 31, 2024 | -96.70% |
| Dec 31, 2023 | -121.84% |
| Sep 30, 2023 | -168.76% |
| Jun 30, 2023 | -151.78% |
| Mar 31, 2023 | -158.14% |
| Dec 31, 2022 | -191.87% |
| Sep 30, 2022 | -183.46% |
| Jun 30, 2022 | -152.86% |
| Mar 31, 2022 | -185.89% |
| Dec 31, 2021 | -97.79% |
| Sep 30, 2021 | -79.47% |
| Jun 30, 2021 | -68.98% |